Eco Animal Health Group PLC Market Authorisation in Indonesia (3609B)

TIDMEAH

RNS Number : 3609B

Eco Animal Health Group PLC

30 January 2020

30 January 2020

ECO Animal Health Group plc

(the "Group")

(AIM: EAH)

Marketing Authorisation in Indonesia

ECO Animal Health Group plc, is pleased to announce that its subsidiary ECO Animal Health Limited (ECO) has received a marketing authorisation from the Ministry of Agriculture, Directorate General of Livestock and Animal Health of the Republic of Indonesia. The agreement is for the use of Aivlosin(R) water soluble granules in chickens laying eggs for human consumption, with a zero day drug withdrawal period for eggs. This approval has been granted under the Group's other brand name Valosin(R).

Aivlosin(R) , ECO's patented antimicrobial, is used under veterinary prescription for the treatment of a variety of economically important respiratory and enteric (gut) diseases in poultry and pigs.

Marc Loomes, CEO of ECO Animal Health Group plc, commented "Indonesia is ranked the number one market in Southeast Asia, and eighth globally, for laying bird numbers. Although the market is currently somewhat fragmented, we expect this to change in the future. It is key that the consumption of Aivlosin provides a zero day drug withdrawal period for eggs which is a significant competitive advantage for ECO. This latest approval demonstrates ECO's continued progress in rolling out this indication for commercial layers."

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

Contacts:

 
ECO Animal Health Group plc 
 Marc Loomes (CEO) 
 Christopher Wilks (CFO)                020 8447 8899 
IFC Advisory 
 Graham Herring 
 Zach Cohen                             020 3934 6630 
N+1 Singer (Nominated Adviser & Joint 
 Broker) 
 Mark Taylor 
 Peter Steel 
 Alex Bond                              020 7496 3000 
Peel Hunt LLP (Joint Broker) 
 James Steel 
 Dr Christopher Golden                  020 7418 8900 
 

ECO Animal Health Group plc ("ECO" or "the Group") researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

AGRSEEEFUESSEIF

(END) Dow Jones Newswires

January 30, 2020 02:01 ET (07:01 GMT)